A Phase I/II, Randomised, Placebo-controlled, Partially-blinded, Parallel-group Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Eurocine
- 07 Apr 2017 According to Eurocine media release, results are expected in June/July 2017.
- 10 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2016 According to an Eurocine media release, first subject has been dosed in the study and the results are expected around mid-2017.